CLINICAL_TRIALS
trial_result
· 2026-02-27
Clinical Trial Update: 18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC [NA]
Summary
A completed clinical trial investigates 18F-PD-L1 PET/CT imaging in nivolumab-treated non-small cell lung cancer patients (Stage IV).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Netherlands Cancer Institute | Conditions: NSCLC Stage IV | NA | Status: COMPLETED